Navigation Links
ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
Date:1/7/2009

native to current therapies."

ImQuest and Samjin have continued their strategic efforts to develop additional pyrimidinediones as next generation NNRTIs with an enhanced genetic barrier to resistance as well as efforts to develop a topical microbicide to prevent the sexual transmission of HIV. Additionally, ImQuest's development of Samjin's piperazine anti-tumor agents for the treatment of both solid and hematopoietic tumors has progressed to IND-enabling toxicology evaluations. These products are expected to enter human clinical trials in late 2009 and 2010.

ImQuest Life Sciences (www.imquestls.com) in Frederick, Maryland specializes in the preclinical and clinical development of novel compounds for the treatment of infectious disease and cancer. ImQuest BioSciences (www.imquest.com) is a leading provider of anti-infective and anti-cancer drug and vaccine development services to the biotechnology and pharmaceutical industry. Established in 1968, Samjin Pharmaceutical Co. (www.samjinpharm.co.kr/eng) is dedicated to the manufacture, distribution and marketing of novel pharmaceuticals resulting in numerous international patents covering antiviral, anticancer, and metabolic candidate compounds. The company has recently expanded their scope to include stem cell research and the active pursuit of diabetic treatments.


'/>"/>
SOURCE ImQuest Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
2. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
3. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
4. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
5. U.S. Naval Medical Research Center Resubmits IND Application for Proposed Op RESUS Clinical Trial in Trauma Patients in the Battlefield Setting
6. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
7. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
8. U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R)
9. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
10. AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
11. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ...armaceutical ingredients (APIs), announced that it... Safety Certification from,SafeBridge(R) Consultan...ompetency and proficiency in the safe handling of ...nd applies to specific laboratories and,production...
(Date:11/19/2009)...ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/ ... ABT ) as one of its Most Admired Corporate Deal... honored Abbott as its Most Admired Dealmaker in ...e of acquisitions and divestitures since January 2...ed its business portfolio with a focus on high-gro...
(Date:11/19/2009)..., Part of International Internet Week of Action ...wswire/ -- The U.S. Food and Drug Administration t...nal effort, called the International Internet Week...s involving medical products. ,, (Logo: http:/..., During the effort, the FDA,s Office of Crimin...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Clinical Trial Results of Pollogens TriPollar 28TM 29 Radio Frequency Technology published in the Journal of the European Academy of Dermatology and V 4515 1Clinical Trial Results of Pollogens TriPollar 28TM 29 Radio Frequency Technology published in the Journal of the European Academy of Dermatology and V 4515 2Most common brain cancer may start in neural stem cells 47615 1Most common brain cancer may start in neural stem cells 47615 2Most common brain cancer may start in neural stem cells 47615 3Most common brain cancer may start in neural stem cells 47615 4More stringent evaluation on the use of generic medications in thoracic transplantation 47611 1More stringent evaluation on the use of generic medications in thoracic transplantation 47611 2
... 9 /CNW/ - Insmed Inc. (NASDAQ:INSM), a ,biopharma...proval,of drugs for the treatment of metabolic di...that it will present at this,week,s C.E. Unterberg...erence in New York City. , The conference, to b... City, will run from Tuesday, July 10th through Th...
...INESS WIRE)--Jul 6, 2007 - Neurologix, Inc.,(OTCBB...elopment of,innovative gene therapies for the brai... the company will present at the Third Annual,C.E....esday July,10, 2007 at 4:30 pm ET at The Mandarin ...xecutive Officer John Mordock will discuss,Neurolo...
Other Medicine Technology:Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
(Date:11/22/2009)...; Machine post You Tube video demonstrating the Re... Landover, MD (PRWEB) November 2...earning what a really rugged waterproof keyboard c...Keyboard vs Washable Competitors Keyboard HD&rdquo...he premium, Really Cool Keyboard from Man & M...
(Date:11/21/2009)...s for an unprecedented expansion of federally-fund...t for preserving and protecting human life? If the...aine Yoest ,, WASHINGTON, Nov. 21 /PRNewswire...resident and CEO Dr. Charmaine Yoest responded to ...owing statement: ,, "This was a pro-abortion v...
(Date:11/21/2009)... 2009 Test Test Test Tes...t Test Test Test Test Test,Test Test Test Test Tes...t,Test Test Test Test Test Test Test Test Test Tes...st More test More test More test More test,More te...st More test More,test More test , , Please ig...
(Date:11/21/2009)...Hall, president and chief executive officer of the...e following statement regarding the inclusion of c...nnual wellness for Medicare beneficiaries in "...ot; that was introduced last night: , ...9 -- Eric J. Hall, president and chief executive o...
(Date:11/20/2009)... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals ...areholders will be held on Monday, December 21, 20...oval of two special resolutions. The first special...f all or substantially all of the assets of NUCRYS...asset purchase agreement dated November 10, 2009 a...
Breaking Medicine News(10 mins):Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3
...ork based Columbia University Medical Center has s... some form of alcohol use disorder at some point ... the adults surveyed reported experiencing alcohol...f the JAMA/Archives journals, states that alcohol ...
...e for 1,000 pounds a measure. Available at...he rare Johnnie Walker 1805 has just gone on sale....200 bottles have been made to celebrate the birthd...distilleries which have since shut down. None of t...
...in sickness (AMS), which affects about half of tho...life-threatening complications such as pulmonary o...al public in AMS is thought to have increased over...rent changes, it is unknown whether there is an ac...
... a British Youngman willingly came forward to dona...the transplant has been successful. Da...re speaking after The 20-year-old David Lomas from... at first and I thought he meant he wanted me to g...
...ion of 2003 have not absorbed dangerous levels of ...f print in Occupational and Environmental Medicine...mbat to pierce armoured vehicles, and spontaneousl...essed many years after potential exposure, using a...
...earchers at Northwestern University has shown that...onsecutive days, they no longer attempt to catch u... The study suggests that repeated partial s...s to acute sleep loss. Published in the Pr...
Other Medicine News:Health News:One-third of Adults Have Had Some Form of Alcohol Use Disorder During Their Lifetimes 2Health News:Scot's National Drink, Now Available at 1,000 Pounds a Nip 2Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Son Donates Part of Liver to Ailing Father, Transplant Successful 2Health News:Lost Sleep can Never Be Compensated for 2
Scleral Blade tip 5700 style, straight
Blade Tip Handle
19 g MVR Knife
Full Handle Laseredge Slit Blade Knife, 3.2 mm angled bevel up
Medicine Products: